Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

SUPN — Supernus Pharmaceuticals, Inc.

NASDAQ
$44.52-1.03 (-2.27%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$32.83
$59.68
$44.35
$45.67
EPS (TTM)$-0.51
P/E Ratio-72.43
Dividend Yield—
Market Cap$2.70B
Volume322K
Prev Close$45.61
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$207.7M-$2.3M$-0.0488.7%-1.1%
Q4 '25$211.6M-$4.1M$-0.0789.1%-1.9%
Q3 '25$192.1M-$45.1M$-0.8074.8%-23.5%
Q2 '25$165.5M$22.5M$0.4089.8%13.6%
Q1 '25$149.8M-$11.8M$-0.2189.5%-7.9%
Q4 '24$174.2M$15.3M$0.2785.0%8.8%
Q3 '24$175.7M$38.5M$0.6990.0%21.9%
Q2 '24$168.3M$19.9M$0.3689.4%11.8%
Get Your Daily Market Recap